Official 2024 U.S. DOL Form 5500 summary for Cytovance Biologics, INC. (Cytovance Biologics, INC. 401(k) Profit Sharing Plan & Trust · EIN 20-3483209 · PN 001): $18.78M net assets, 192 active participants, and $10.46 per $10,000 (10.46 bps).
| Plan Sponsor | Cytovance Biologics, INC. |
|---|---|
| Filing Identifier | Cytovance Biologics, INC. 401(k) Profit Sharing Plan & Trust · EIN 20-3483209 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (OK) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2024) | $18.78M |
| Active Participants | 192 |
| Direct Admin Fee Rate | $10.46 per $10,000 (10.46 bps) |
| Cohort Peer Median | $37.06 per $10,000 (37.06 bps) |
| Primary Recordkeeper / Provider | ADP Retirement Services |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($57,905, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI